Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0956 CHF | -1.65% | +9.89% | +107.83% |
Mar. 08 | ADRs Close Lower, Lixiang Education Holding Co. Ltd. Declines 19.6% | DJ |
Jan. 31 | Addex Therapeutics Plans Sale of American Depositary Shares | MT |
Business Summary
Number of employees: 24
Sales per Business
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -54.18% |
Sales per region
CHF in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -54.18% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Chairman | 75 | 09-04-15 | |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Corporate Officer/Principal | - | 02-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Chairman | 75 | 09-04-15 | |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Isaac Manke
BRD | Director/Board Member | 47 | 17-12-31 |
Ray Hill
BRD | Director/Board Member | 79 | 08-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 184,354,496 | 91,845,495 ( 49.82 %) | 61,561,142 ( 33.39 %) | 49.82 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44,113,438 | 23.93% | 3,136,024 $ |
Company contact information
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+107.83% | 15.08M | |
+9.05% | 45.97B | |
+52.84% | 43.93B | |
+9.77% | 42.34B | |
-8.59% | 28.27B | |
+17.78% | 27.18B | |
-20.30% | 19.44B | |
+13.94% | 13.83B | |
+31.43% | 12.4B | |
+8.89% | 11.45B |
- Stock
- Equities
- Stock Addex Therapeutics Ltd - Swiss Exchange
- Company Addex Therapeutics Ltd